English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Patient Daily
| Feb 23, 2026
Norwegian study explores challenges of funding high-cost drugs for rare diseases
Patient Daily
| Feb 23, 2026
Study links insufficient sleep to higher risk of heart rhythm disorder
Patient Daily
| Feb 23, 2026
Gut microbiome linked to varied responses for obesity and diabetes drugs
Patient Daily
| Feb 23, 2026
Study links prenatal infection with higher adult alcohol misuse risk; antioxidants may help
Patient Daily
| Feb 23, 2026
Study finds low COVID-19 and flu vaccination rates among pregnant women in Norway
Patient Daily
| Feb 23, 2026
AI-driven DeepRare system shows promise for faster rare disease diagnosis
Patient Daily
| Feb 23, 2026
Study links infant sensory sensitivity with reduced quality of deep sleep
Patient Daily
| Feb 23, 2026
Gut microbiome analysis may help identify severe insulin resistance in type 2 diabetes
Trending
+
Regulatory
A. D. Alderman
| Jun 11, 2026
Pharmacist Crisp on PBM reform bills: 'Middleman that owns the pharmacy, sets the price, pays itself, and audits its own books'
+
Regulatory
A. D. Ahrens
| Jun 11, 2026
Economist: 'The 340B program has been hijacked by tax-exempt hospitals'
+
Regulatory
Patient Daily
| Jun 16, 2026
PhRMA official: 'A program meant to help vulnerable patients shouldn't be treated like a business strategy'
+
Regulatory
Patient Daily
| Jun 12, 2026
Taxpayer advocate: 340B drug discount program offers 'perverse incentives'
« First
«
…
78
79
80
81
82
83
84
…
»
Last »